NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cellevate AB

Cellevate AB

Private
LundHealthcare & Life Scienceshttps://cellevate.com/

Last Round

VC Round

Feb 1, 2026

Total Funding Raised

$6.97M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cellevate AB is a biotechnology company that offers next-generation cell culture products for upstream bioprocessing, powered by its proprietary nanofiber technology.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Advanced Materials, Sustainable Materials, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

nanofiber microcarriers3D cell cultureupstream bioprocessingviral vector productioncell and gene therapyCGT manufacturingbiopharmaceutical manufacturingbioprocess intensificationvaccine productionnanofiber scaffoldbioreactor consumablesAAV productionCDMO toolsiPSCsinduced pluripotent stem cellscellulose microcarriers

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellevate AB Comps

Public and private peers based on sector, stage, and business model.

Cellevate AB comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellevate AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 1, 2026
GrantApr 25, 2025
SeedSep 16, 2024
SeedOct 10, 2023

Key People

Founding team and executive leadership

Laura Chirica

Chief Executive Officer

Executive Team

Christel Fenge

Chief Technology Officer

Executive Team

Linda Dexlin Mellby

Chief Operating Officer, Vice President Research And Development

Executive Team

Cellevate AB Investors

Notable investors and investment history

Cellevate AB investors
InvestorRounds
European Innovation CouncilSeed
Eurostars SME programmeGrant
Onsight VenturesSeed
Almi Invest ABVC Round
IndustrifondenVC Round, Seed
EIC FundVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    $1.94M round with Almi Invest, Industrifonden, and EIC Fund.

  • Apr 25, 2025

    Received funding from the Eurostars SME programme.

Cellevate AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellevate AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellevate AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersLund
Employee Range21
Year Founded2014
Last FundingFeb 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.